Evidence map›Paper›PMID 42294707›Full record

ArticleMicrobiology spectrum2026

From screening to treatment:

Lan Liao, Shanchen Yang, Gang Luo, Ruidong Wu, Rongjing Lu, Yushan Huang, Guanfeng Wu, Wei Yi, Zhu Zeng, Zhilang Qiu and 1 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lan Liao *Guizhou Key Laboratory of Microbio and Infectious Diseases Prevention & Control, School of Biology and Engineering (School of Modern Industry for Health and medicine)/School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Shanchen Yang *Guizhou Key Laboratory of Microbio and Infectious Diseases Prevention & Control, School of Biology and Engineering (School of Modern Industry for Health and medicine)/School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Gang Luo *Guizhou Key Laboratory of Microbio and Infectious Diseases Prevention & Control, School of Biology and Engineering (School of Modern Industry for Health and medicine)/School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Ruidong WuGuizhou Key Laboratory of Microbio and Infectious Diseases Prevention & Control, School of Biology and Engineering (School of Modern Industry for Health and medicine)/School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Rongjing LuGuizhou Key Laboratory of Microbio and Infectious Diseases Prevention & Control, School of Biology and Engineering (School of Modern Industry for Health and medicine)/School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Yushan HuangGuizhou Key Laboratory of Microbio and Infectious Diseases Prevention & Control, School of Biology and Engineering (School of Modern Industry for Health and medicine)/School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Guanfeng WuGuizhou Key Laboratory of Microbio and Infectious Diseases Prevention & Control, School of Biology and Engineering (School of Modern Industry for Health and medicine)/School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Wei YiGuizhou Key Laboratory of Microbio and Infectious Diseases Prevention & Control, School of Biology and Engineering (School of Modern Industry for Health and medicine)/School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.
Zhu ZengGuizhou Key Laboratory of Microbio and Infectious Diseases Prevention & Control, School of Biology and Engineering (School of Modern Industry for Health and medicine)/School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.ORCID 0000-0003-1989-5142
Zhilang QiuGuizhou Key Laboratory of Microbio and Infectious Diseases Prevention & Control, School of Biology and Engineering (School of Modern Industry for Health and medicine)/School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.ORCID 0000-0003-1203-0517
Jian PengGuizhou Key Laboratory of Microbio and Infectious Diseases Prevention & Control, School of Biology and Engineering (School of Modern Industry for Health and medicine)/School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, China.ORCID 0000-0003-3047-1455

Funding

Engineering Research Center of Health Medicine biotechnology of Institution of higher education of Guizhou Province Qian Jiao Ji No[2023]036QKH Basic MS [2025]555,ZK[2022] General 349the Guizhou Key Laboratory of Microbiome and Infction Disease Pervention& Control, China ZDSYS [2023] 004the High-Level Talent Initiation Province of Guizhou Medical University J[2022]023the Natural Science Foundation of Guizhou Province ZK [2021] Zhongdian 030,ZK [2022] Key Programo39Undergraduate innovation and entrepreneurship Project S202310660074,S202410660556,S2024106601292,S202310660080
6 · The paper itself

Abstract

Carbapenem-resistant IMPORTANCE: This study focused on phage-antibiotic combination therapy targeting carbapenem-resistant

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsBacteriophagesMeropenemPhage TherapyAnimalsCarbapenemsFemaleHumansLarvaMiceMicrobial Sensitivity TestsMothsVirulenceAnti-Bacterial AgentsCarbapenemsMeropenemCRABphage therapyquorum sensingvirulence

Identifiers

PMID42294707
PMCPMC13340115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.